T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
TriNet
TNET
$3.22B
| $24.5M | ﹤0.01% |
244,633
+8,630
| +4% | +$961K |
|
902
Immunome
IMNM
$3B
| $24.5M | ﹤0.01% |
2,021,119
-224,554
| -10% | -$3.51M |
|
903
Green Brick Partners
GRBK
$3.04B
| $24.3M | ﹤0.01% |
425,048
-86,434
| -17% | -$4.83M |
|
904
Jacobs Solutions
J
$16.8B
| $24.3M | ﹤0.01% |
210,321
+6,173
| +3% | +$724K |
|
905
T. Rowe Price Growth Stock ETF
TGRW
$1.04B
| $24.2M | ﹤0.01% |
+650,001
| New | +$22.6M |
|
906
Principal Financial Group
PFG
$24.6B
| $24.2M | ﹤0.01% |
307,878
+6,557
| +2% | +$532K |
|
907
MGM Resorts International
MGM
$11.1B
| $24.1M | ﹤0.01% |
541,448
-21,996
| -4% | -$919K |
|
908
Clorox
CLX
$12.9B
| $23.9M | ﹤0.01% |
175,342
+2,575
| +1% | +$358K |
|
909
CNX Resources
CNX
$5.23B
| $23.8M | ﹤0.01% |
980,244
+867,985
| +773% | +$21.2M |
|
910
Labcorp
LH
$26.2B
| $23.8M | ﹤0.01% |
117,045
+2,557
| +2% | +$520K |
|
911
Waters Corp
WAT
$40.6B
| $23.7M | ﹤0.01% |
81,852
+1,539
| +2% | +$491K |
|
912
Citizens Financial Group
CFG
$31.2B
| $23.6M | ﹤0.01% |
654,003
+12,430
| +2% | +$433K |
|
913
Amphastar Pharmaceuticals
AMPH
$858M
| $23.4M | ﹤0.01% |
583,906
-638
| -0.1% | -$26.4K |
|
914
iRhythm Holdings
IRTC
$4.06B
| $23.3M | ﹤0.01% |
216,759
-3,862
| -2% | -$395K |
|
915
Invesco
IVZ
$14.3B
| $23.2M | ﹤0.01% |
1,552,428
+55,023
| +4% | +$846K |
|
916
ADMA Biologics
ADMA
$2.11B
| $23.2M | ﹤0.01% |
2,076,328
+2,015,404
| +3,308% | +$16.9M |
|
917
Photronics
PLAB
$1.97B
| $23.2M | ﹤0.01% |
938,445
+97,907
| +12% | +$2.66M |
|
918
Arm
ARM
$298B
| $23.1M | ﹤0.01% |
140,999
-149,948
| -52% | -$18.6M |
|
919
NRG Energy
NRG
$25.2B
| $23M | ﹤0.01% |
296,002
-20,842
| -7% | -$1.61M |
|
920
LeMaitre Vascular
LMAT
$1.87B
| $23M | ﹤0.01% |
279,282
+273,639
| +4,849% | +$20.1M |
|
921
Academy Sports + Outdoors
ASO
$3.03B
| $23M | ﹤0.01% |
431,446
-30,972
| -7% | -$1.76M |
|
922
Allegion
ALLE
$14.2B
| $22.8M | ﹤0.01% |
193,301
-36,600
| -16% | -$4.51M |
|
923
Mid-America Apartment Communities
MAA
$15.6B
| $22.8M | ﹤0.01% |
159,668
+3,762
| +2% | +$503K |
|
924
CRISPR Therapeutics
CRSP
$5.22B
| $22.7M | ﹤0.01% |
420,695
-179,539
| -30% | -$10.4M |
|
925
Warner Bros
WBD
$69.6B
| $22.7M | ﹤0.01% |
3,047,787
+56,947
| +2% | +$456K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.